Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress of visual dysfunction in Parkinson's disease.

T Müller1, D Woitalla, S Peters

  • 1Department of Neurology, St Josef-Hospital, Ruhr-University of Bochum, 44791 Bochum, Germany. thomas.mueller@ruhr-uni-bochum.de

Acta Neurologica Scandinavica
|April 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Role of dopamine agonists in Parkinson's disease therapy.

Journal of neural transmission (Vienna, Austria : 1996)·2023
Same author

Role of dopamine agonists in Parkinson's disease therapy.

Journal of neural transmission (Vienna, Austria : 1996)·2023
Same author

S1 guidelines "lumbar puncture and cerebrospinal fluid analysis" (abridged and translated version).

Neurological research and practice·2020
Same author

Polypharmacy in Parkinson's disease: risks and benefits with little evidence.

Journal of neural transmission (Vienna, Austria : 1996)·2019
Same author

[Parkinson's Disease at the Border Between Inpatient and Outpatient Care].

Fortschritte der Neurologie-Psychiatrie·2016
Same author

Parkinson disease and multiple sclerosis are not associated with autoantibodies against structural proteins of the dermal-epidermal junction.

The British journal of dermatology·2016

Parkinson's disease (PD) affects color vision. This study found that color vision deterioration progresses alongside PD intensity over three years.

Area of Science:

  • Neurology
  • Ophthalmology
  • Neuroscience

Background:

  • Parkinson's disease (PD) research predominantly examines dopaminergic decline in the nigrostriatal pathway.
  • The visual system's role in PD progression remains understudied.
  • Color vision deficits may represent an early or parallel indicator of neurodegeneration in PD.

Purpose of the Study:

  • To investigate the progression of disturbed color vision in Parkinson's disease patients.
  • To correlate changes in color vision with the overall intensity of PD over time.
  • To explore the relationship between visual system changes and daily living activities in PD.

Main Methods:

  • Longitudinal study involving 18 Parkinson's disease patients.
  • Assessment of color vision using the Farnsworth-Munsell 100 Hue test (FMT).

Related Experiment Videos

  • Quantification of PD intensity and evaluation of daily living activities at baseline and 3-year follow-up.

    • Main Results:

    • Significant progression in both color vision errors (FMT scores) and PD intensity was observed over 3 years (P=0.002 for both).
    • A notable correlation was found between the degree of color vision deterioration and the severity of functional impairment in daily activities.
    • These findings indicate a parallel progression of visual deficits and motor symptoms in Parkinson's disease.

    Conclusions:

    • Color vision impairment is a progressive feature in Parkinson's disease.
    • Monitoring visual system changes, particularly color vision, may offer insights into PD progression and patient well-being.
    • Further research into the visual system's involvement in PD is warranted.